Trans American Aquaculture (GRPS) Revenue (2023 - 2024)
Trans American Aquaculture (GRPS) reported Revenue of $16500.0 for Q4 2024, down 83.76% on a YoY basis from $101574.0 in Q1 2024, and up 228.75% quarter-over-quarter from $5019.0 in Q2 2024.
Trans American Aquaculture (GRPS) Revenue (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported Revenue for 2 years, with the latest figure at $16500.0 in Q4 2024.
- For the quarter ending Q4 2024, Revenue fell 83.76% year-over-year to $16500.0; the trailing twelve-month figure through Sep 2025 stood at $16500.0 (down 96.04% YoY), and the FY2024 full-year result was $331645.0, up 226.51% from the prior year.
- Revenue for Q4 2024 stood at $16500.0, up from $5019.0 in the prior quarter.
- The five-year high for Revenue was $310126.0 in Q1 2024, with the low at $5019.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 16,500.00 |
| Jun 30, 2024 | 5,019.00 |
| Mar 31, 2024 | 310,126.00 |
| Dec 31, 2023 | 101,574.00 |